Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,800 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 July 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 4MB, 236 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 41 results:
Author [ Title(Desc)] Type Year
Filters: Author is Khunti, K.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
S. de Lusignan, Liaw, S. T., Dedman, D., Khunti, K., Sadek, K., and Jones, S., An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR), J Innov Health Inform, vol. 22, pp. 255-64, 2015.
R. Palladino, Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., and Vamos, E. P., Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes, BMJ Open Diabetes Res Care, vol. 8, 2020.
K. Khunti, Danese, M. D., Kutikova, L., Catterick, D., Sorio-Vilela, F., Gleeson, M., Seshasai, S. R. Kondapa, Brownrigg, J., and Ray, K. K., Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe, JAMA Netw Open, vol. 1, p. e185554, 2018.
S. K. Paul, Klein, K., Majeed, A., and Khunti, K., Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes, J Diabetes, vol. 8, pp. 354-62, 2016.
E. P. Vamos, Harris, M., Millett, C., Pape, U. J., Khunti, K., Curcin, V., Molokhia, M., and Majeed, A., Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study, Bmj, vol. 345, p. e5567, 2012.
C
B. Coles, Zaccardi, F., Ling, S., Davies, M. J., Samani, N. J., and Khunti, K., Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population, J Diabetes Investig, 2020.
B. Coles, Zaccardi, F., Hvid, C., Davies, M. J., and Khunti, K., Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real-world study of patients followed for up to 19 years, Diabetes Obes Metab, vol. 23, pp. 218-227, 2021.
J. P. H. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice., Diabetologia., vol. 60, p. S301, 2017.
J. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink, BMC Med, vol. 16, p. 116, 2018.
K. Khunti, Wolden, M. L., Thorsted, B. L., Andersen, M., and Davies, M. J., Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people, Diabetes Care, vol. 36, pp. 3411-7, 2013.
K. Khunti, Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., and Paul, S. K., Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin, Diabetes Obes Metab, vol. 18, pp. 401-9, 2016.
F. Zaccardi, Jacquot, E., Cortese, V., Tyrer, F., Seidu, S., Davies, M. J., and Khunti, K., Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes, Diabetes Obes Metab, 2020.
K. C. Chang, Soljak, M., Lee, J. T., Woringer, M., Johnston, D., Khunti, K., Majeed, A., and Millett, C., Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study, Prev Med, vol. 78, pp. 1-8, 2015.
[Page last reviewed 5 July 2021]